Plasma ADMA associates with all-cause mortality in renal transplant recipients

Asymmetric dimethylarginine (ADMA) is a key endogenous inhibitor of endothelial NO synthase that affects endothelial function, blood pressure and vascular remodeling. Increased plasma levels of ADMA are associated with worse outcome from cardiovascular disease. Due to endothelial dysfunction before...

Descripción completa

Detalles Bibliográficos
Autores principales: Frenay, Anne-Roos S., van den Berg, Else, de Borst, Martin H., Beckmann, Bibiana, Tsikas, Dimitrios, Feelisch, Martin, Navis, Gerjan, Bakker, Stephan J. L., van Goor, Harry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549386/
https://www.ncbi.nlm.nih.gov/pubmed/26077715
http://dx.doi.org/10.1007/s00726-015-2023-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549386/
https://www.ncbi.nlm.nih.gov/pubmed/26077715
http://dx.doi.org/10.1007/s00726-015-2023-0

Ejemplares similares